Manulife Financial, one of Canada's largest insurers, reported second-quarter core earnings that came in slightly above analyst expectations, helped by faster growth in its Asian operations and its global wealth and asset-management business. The company also used the earnings release to highlight a new risk-management deal with Munich Re that reinsures C$3.2 billion of long-term care reserves.
Core earnings for the quarter were C$1.09 per share, up from C$0.95 a year earlier and a touch above the C$1.08 that analysts tracked by FactSet had expected. The company pointed to broad sales momentum, with Asia and the wealth and asset-management arm doing much of the heavy lifting.
What's driving the growth
Manulife has been expanding aggressively in Asia for years, where a growing middle class and rising demand for insurance products have made the region a key growth engine. The company's wealth and asset-management business has also benefited from higher interest rates, which can boost returns on fixed-income investments and make insurance products more attractive.
The earnings beat comes at a time when many insurers are navigating a mixed environment. Higher interest rates generally help insurers by increasing investment income, but they can also weigh on demand for certain products. Manulife's ability to grow sales across multiple segments suggests it is managing those pressures well.
Investors have been watching Manulife's progress in Asia closely, as the region offers higher growth potential than its more mature North American markets. The company's performance there has been a key driver of its stock price in recent years.
The long-term care reinsurance deal
Manulife also announced a significant risk-transfer agreement with Munich Re, one of the world's largest reinsurers. Under the deal, Munich Re will reinsure C$3.2 billion of Manulife's long-term care reserves. This is expected to reduce Manulife's sensitivity to long-term care morbidity risk—the risk that policyholders need care more often or for longer than expected—by 24%.
Long-term care insurance has been a challenging line of business for many insurers, as claims have often exceeded initial assumptions. By reinsuring a portion of these reserves, Manulife is offloading some of that risk to Munich Re, which can help stabilize its earnings and free up capital.
This type of transaction is common in the insurance industry, where companies use reinsurance to manage exposure to large or uncertain risks. For Manulife, the deal is part of a broader effort to reduce volatility in its long-term care block and focus on its core growth areas.
What it means for investors
For everyday investors, the key takeaway is that Manulife is delivering steady earnings growth while also taking steps to reduce risk. The beat on estimates is modest, but the underlying momentum in Asia and wealth management is encouraging.
The reinsurance deal with Munich Re is also a positive signal. It shows that Manulife is proactively managing its long-term care liabilities, which have been a source of concern for investors in the past. By reducing its sensitivity to that risk, the company is making its earnings stream more predictable.
That said, investors should keep in mind that insurance companies are exposed to a range of factors, including interest rates, investment returns, and claims experience. While the current environment is supportive, conditions can change.
Manulife's results come amid a broader earnings season where many companies are beating expectations. For instance, the S&P 500 has hit record highs as earnings surge, but some caution is creeping in. In that context, Manulife's steady performance stands out as a sign of resilience.
Investors looking at Manulife should also consider the broader insurance landscape. Some companies are cutting outlooks, but Manulife's guidance remains positive, with growth in Asia and wealth management expected to continue.
As always, it's important to look beyond a single quarter. Manulife's long-term success will depend on its ability to sustain growth in Asia, manage its legacy long-term care book, and navigate the interest rate cycle. The latest results suggest the company is on a solid footing.
